Tevogen Bio Holdings Inc. — Income Charts
10 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-400.4% -$50K
$-62K
R&D↓-4.6% -$150K
$3M
D&A↓-98.7% -$40K
$518
Operating Income↑+5.9% +$356K
$-6M
EBITDA↑+5.2% +$316K
$-6M
Interest Expense↓-84.2% -$131K
$25K
Interest Income
$334K
Net Income↑+2.7% +$157K
$-6M
Operating Margin↓-39653.8pts
9190.6%
Net Margin↓-38042.3pts
9186.4%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+10.1pts
12.3%
Revenue YoY Variation
-400.4%
Income YoY Variation↑+167.6pts
5.9%
Revenue QoQ Variation↑+207686.1pts
-63.9%
Income QoQ Variation↓-34.5pts
-5.2%